r&d

The U.S. National Science Foundation announced a new $60 million investment led by NSF's Directorate for Technology, Innovation and Partnerships — the Accelerating Research Translation, or ART, program. The program will build capacity and infrastructure at higher education institutions that are needed to strengthen and scale the translation of basic research outcomes into impactful solutions and practice.

Microbusinesses (businesses with 1-9 domestic employees) spent $7.5 billion in both domestic and foreign R&D expenditures or costs in 2020, of which $6.7 billion was in the U.S. Of this total, $5.6 billion was performed by microbusinesses themselves, according to the National Center for Science and Engineering Statistics (NCSES) and data from the Annual Business Survey (ABS). The $5.6 billion performed by U.S. microbusinesses in 2020 shows over a $1 billion increase in domestic R&D performed by microbusinesses themselves as compared to 2018.

A previous Digest article gave a broad overview of the most recent survey of Higher Education Research and Development (HERD) for FY 2021 (the most recent data available), including a breakdown of what field of studies receive the most R&D funding. The survey showed that the federal government funds the bulk of higher-ed R&D, and looking at each of its agencies can shed light on investment priorities. Within the federal government, Health and Human Services (HHS) funded the most higher-ed R&D activities by far (approximately $27.5 billion), followed by the Department of Defense (DoD; $7.4 billion) and National Science Foundation (NSF; $5.4 billion). A bulk of HHS funding went toward the life sciences ($24.2 billion), with engineering following behind at approximately $1 billion. DoD primarily funded engineering ($3.7 billion), followed by life sciences ($1.4 billion).

New fiscal year (FY) 2021 Higher Education Research & Development (HERD) survey data released by the National Science Foundation (NSF) reveals a $3.4 billion (4%) increase in research and development (R&D) spending by institutions of higher education ($86.5 to $89.9 billion), driven almost entirely by a decades high federal government R&D funding increase of $3 billion.

State government agencies’ expenditures for research and development totaled nearly $2.5 billion in FY 2021, an increase of 1.1% from FY 2020, but far below the year-over-year inflation of 6.4% when measured in February 2022. The findings on state R&D were recently reported by the National Center for Science and Engineering Statistics (NCSES). The sluggish state spending was exacerbated by real decline in extramural share of federal R&D spending in FY 2021. Intramural R&D by feds grew from 30.7% of total in FY 2020 to 35.8 percent in FY 2021 (see https://ncses.nsf.gov/pubs/nsf22323).

A report from ITIF exploring the factors involved in ecosystem strength found that states in Germany generally perform better than states in the U.S., Italy, and Canada in terms of globalization, knowledge economy, and innovation capacity.

Despite COVID-induced setbacks continuing to keep some people out of offices and laboratories, new Business Enterprise Research and Development Survey (BERD) data reveals that domestic research and development (R&D) spending, although slowing, is still on an uptrend. From 2018 to 2019, business R&D spending increased by 11.8% (from approximately $441 billion to $492 billion), with new data showing a further increase of 9.1% from 2019 to 2020 ($492 billion to $538 billion).

On the heels of President Biden’s recent announcement of a Biotechnology and Biomanufacturing Initiative to boost the United States bioeconomy, the Congressional Research Service (CRS) has released The Bioeconomy: A Primer, which examines the future of the bioeconomy, explores the United States’ competitiveness in global bioeconomy efforts, and notes the current lack of federal coordination on building the bioeconomy. To address this lack of coordination, the report urges Congress to develop a more comprehensive national strategy for establishing the bioeconomy.   

Accelerators, incubators and entrepreneurial assistance programs work to ensure their startups understand their product’s market competition, customers, and supply chain. As it turns out, that’s also good advice for small research-based firms trying to move from SBIR proof-of-concept funding to securing the larger Phase II awards. A survey of approximately 250 National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program awardees by researchers finds market information from suppliers, customers, and competitors to be key for small entrepreneurial firms to increase publicly funded research and development (R&D) effectiveness.

The White House Office of Management and Budget and the Office of Science and Technology Policy jointly issued a memorandum to all federal agencies outlining an expanded list of research and development priorities. The document is intended to guide all executive branch offices and agencies as they put together their budget requests for fiscal year 2024. Nearly twice as long as the Biden administration's priority memo last year, the updated list includes more priorities and more details drilling deeper into the top concerns.